• Tues news: Prostate cancer trials to watch. Merck’s subcutaneous Keytruda. Apellis sees positive in Astellas CRL. Future of Medicare price negotiations. JNJ psoriasis results. See more on our front page

ABBV STOCK HITS RECORD ALL TIME HIGH

Quote








anonymous said:
You are just taking what was in the article and presuming AbbVie is smart enough to prepare like this. That’s a big stretch given the arrogance of the AbbVie C-Suite leaders. Rick lied on his resume. Do you trust him?
Click to expand...

No I don’t trust Rick. I think he did very well though, but it’s all a dog and pony show. These politicians are all liars as is every person being questioned. Ken Frazier was kissing major political ass today. Only hard question was on executive compensation structure in relation to Humira price which was a no brainer and perfectly legal. They called out rick on Humira EU pricing and the $15B tax breaks. This was a big nothing burger today, with extra nothing. It’s all a charade and only the sheep think Pharma can be controlled by government. Not gonna happen.
 




I heard a brief mention about the academic papers being submitted but didn’t know who the question was directed at. Nothing about ricks travel expense. They only discussed Ricks 2017 comp because his 2018 comp was down 40%. Told y’all this was going to be a crock and a big fat YAWN.
 




Trumps a damn buffoon, when it comes to Corporate tax breaks. Should have NEVER gave the elite a license to steal MORE and buyback stock. The total stock buyback (using tax break) from all (7) of the Pharma company’s testifying today totaled $40B. Abbvie comprises $15B of it. SHAMEFUL!
 








anonymous said:
No I don’t trust Rick. I think he did very well though, but it’s all a dog and pony show. These politicians are all liars as is every person being questioned. Ken Frazier was kissing major political ass today. Only hard question was on executive compensation structure in relation to Humira price which was a no brainer and perfectly legal. They called out rick on Humira EU pricing and the $15B tax breaks. This was a big nothing burger today, with extra nothing. It’s all a charade and only the sheep think Pharma can be controlled by government. Not gonna happen.
Click to expand...

Richard was the most informative and likable of all those testifying. Agree though is all a sham. Politicians are “partners in crime” with money hungry Coroprations.
 




Abbvie can’t keep paying dividends on stock. Watch them sink. The heavy debt load which is never talked about by Rick, could lead to bankruptcy. The negative return on equity for ABBV is a staggering -1,343.27%
 




anonymous said:
Abbvie can’t keep paying dividends on stock. Watch them sink. The heavy debt load which is never talked about by Rick, could lead to bankruptcy. The negative return on equity for ABBV is a staggering -1,343.27%
Click to expand...

The street has no faith in Abbvie being able to manage this insane debt level. RM and MS gave powder puff answers on Barclay conference call.
 
















anonymous said:
Trumps a damn buffoon, when it comes to Corporate tax breaks. Should have NEVER gave the elite a license to steal MORE and buyback stock. The total stock buyback (using tax break) from all (7) of the Pharma company’s testifying today totaled $40B. Abbvie comprises $15B of it. SHAMEFUL!
Click to expand...

Long ball hitter, HQ wants to shut you down. They’re afraid of the data you have from Abbott pertaining to government contracts and pricing abuse. Is there Statutes of limitations and could legal proceedings be initiated?
 




anonymous said:
Long ball hitter, HQ wants to shut you down. They’re afraid of the data you have from Abbott pertaining to government contracts and pricing abuse. Is there Statutes of limitations and could legal proceedings be initiated?
Click to expand...

The data I have covers many different areas. Some are active and others are past 7 statutes limit. I got no beef with Abbvie and don’t need the money, I have plenty. Also don’t need the aggravation and time consumption involved in litigation. The data on Abbott’s partnership with Perdue pushing Oxy is precious and pertains to current events. I sent EVERYTHING I had to DOJ last year.
 
















Weak close/sell off today. ER tomorrow should be Bottom line BEAT and Top line TANK!! EPS around $2.08.Y’all get ready for negative YoY revenue growth for Q1 of -1.7% down from 7.31% in Q418.
 












Top Bottom
Back
Quote